Stay updated on SPR1NT Clinical Trial
Sign up to get notified when there's something new on the SPR1NT Clinical Trial page.

Latest updates to the SPR1NT Clinical Trial page
- CheckyesterdayChange DetectedScreenshots indicate cosmetic UI changes (layout and styling) with no visible modifications to the study data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check30 days agoChange DetectedCore content updated from a specific disease subtype to a broader category and version bumped to v3.2.0; a government operating-status notice was added.SummaryDifference3%

- Check37 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check51 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, specifically St. Louis, Missouri, and the introduction of Zolgensma, a treatment for proximal spinal muscular atrophy. However, many related terms and previous location details have been removed.SummaryDifference2%

Stay in the know with updates to SPR1NT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPR1NT Clinical Trial page.